1 Product identity
Ingredient risk
2 ingredients to use with caution

Shredabull 2.0

BrandAD Elite Series→Other Combinations Capsule 18 ingredients 2 caution DSLD #278029
Net contents: 50 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2022-10-24
2 Ingredients (18)
IngredientGroupSafety
NiacinNiacinConditionally Safe
Vitamin B6Vitamin B6 (unspecified)Use with Caution
CalciumCalciumConditionally Safe
Neurostim BlendProprietary Blend (non-nutrient/non-botanical)—
Caffeine AnhydrousCaffeineUse with Caution
N, N-DimethylphenylethylamineDimethylphenethylamine—
PEAPhenethylamine (PEA)—
N-Acetyl L-TyrosineN-Acetyl Tyrosine—
Incinerate Thermo ComplexProprietary Blend (Combination)—
Gamma Butyrobetaine Ethyl Ester HydrochlorideGamma butyrobetaine—
Higenamine HydrochlorideHigenamine—
White Willow bark extractWhite Willow—
Cayenne extractCapsicum—
Yohimbine HydrochlorideYohimbine—
Thyrocharge ComplexBlend (Combination)—
Bovine ThyroidThyroid—
Guggul Lipid PE extractGuggulLimited Evidence
BioperineBlack Pepper—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Vitamin B6 — Sensory neuropathy from chronic high-dose B6 (>200 mg/day) — presents as numbness, ataxia. Can be irreversible. Often self-prescribed by patients…
Caffeine (Anhydrous)  🇬🇧 🇪🇺 🇦🇺 — High caffeine warnings mandatory on products >150 mg/L.
3 Safety cross-reference
Niacin — Conditionally Safe
⚠ Flushing at >50 mg
⚠ Hepatotoxicity at high doses
Vitamin B6 — Use with Caution
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Caffeine (Anhydrous) — Use with Caution
DIM — Limited Evidence
⚠ Anti-estrogenic effects
⚠ Hormonal disruption possible
L-Tyrosine — Limited Evidence
⚠ May worsen hyperthyroidism
⚠ Migraine trigger in some
Chloride — Limited Evidence
⚠ Co-ingested with sodium
White Willow Bark — Limited Evidence
⚠ Contains salicin (aspirin-like)
⚠ GI irritation
Guggul — Limited Evidence
⚠ GI upset, headache
⚠ Thyroid stimulation
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID278029
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2022-10-24
6 More from AD Elite Series
View AD Elite Series Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Shredabull 2.0 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Jul 30]. Available from: https://supplement.ge/products/shredabull-2-0-278029/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG